Pharma Execs Cast Doubt On Valeant's Compliance Culture

Two men charged with defrauding Valeant Pharmaceuticals International Inc. out of $9.7 million when it moved to buy Philidor Rx Services LLC sought on Friday to rebut claims they hid anything...

Already a subscriber? Click here to view full article